Iroquois Capital Management, LLC 13D and 13G filings for Petros Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-17 10:50 am Purchase | 2025-12-21 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 4,434,773 9.990% | 1,121,069 (+33.83%) | Filing |
| 2025-08-15 08:00 am Sale | 2025-06-30 | 13G | PETROS PHARMACEUTICALS INC PTPI | Iroquois Capital Management, LLC | 3,313,704 9.990% | -2,626,250 (-44.21%) | Filing |